Neuroprotective Effect of YM90K, a Novel AMPA/Kainate Receptor Antagonist, in Focal Cerebral Ischemia in Cats
-
- D. Uematsu
- Department of Neurology, Urawa Municipal Hospital, Saitama, Japan
この論文をさがす
抄録
<jats:p> We studied the effect of a novel α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)/kainate antagonist, YM90K [6-(1 H-imidazol-1-yl)-7-nitro-2, 3(1 H, 4 H)-quinoxalinedione monohydrochloride], in a focal cerebral ischemia model using anesthetized cats. Cats were subjected to permanent occlusion of the middle cerebral artery (MCA) for 6 h, then killed and examined histologically. The amount of ischemic damage was assessed in 12 stereotaxic coronal sections. Treatment with YM90K (i.v. infusion of 0.5 mg/5 ml/kg/h) starting 10 min after MCA occlusion markedly reduced the volume of ischemic damage (from 2823 ± 164 mm<jats:sup>3</jats:sup> of the cerebral hemisphere in saline-treated cats to 1737 ± 305 mm<jats:sup>3</jats:sup> in YM90K-treated cats). No essential differences were observed between YM90K- and saline-treated cats concerning physiological variables or brain temperature. These results further support the notion that the AMPA/kainate receptor plays an important role in the pathogenesis of focal cerebral ischemia. This evidence for the neuroprotective efficacy of YM90K in a gyrencephalic species suggests its therapeutic potential in the treatment of human stroke. </jats:p>
収録刊行物
-
- Journal of Cerebral Blood Flow & Metabolism
-
Journal of Cerebral Blood Flow & Metabolism 16 (5), 959-966, 1996-09
SAGE Publications
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1362825895305141888
-
- NII論文ID
- 30009334891
-
- NII書誌ID
- AA10458430
-
- ISSN
- 15597016
- 0271678X
- http://id.crossref.org/issn/0271678X
-
- データソース種別
-
- Crossref
- CiNii Articles